Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer.

Toyokawa G, Masuda K, Daigo Y, Cho HS, Yoshimatsu M, Takawa M, Hayami S, Maejima K, Chino M, Field HI, Neal DE, Tsuchiya E, Ponder BA, Maehara Y, Nakamura Y, Hamamoto R.

Mol Cancer. 2011 May 28;10:65. doi: 10.1186/1476-4598-10-65.

2.

Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker.

Takawa M, Masuda K, Kunizaki M, Daigo Y, Takagi K, Iwai Y, Cho HS, Toyokawa G, Yamane Y, Maejima K, Field HI, Kobayashi T, Akasu T, Sugiyama M, Tsuchiya E, Atomi Y, Ponder BA, Nakamura Y, Hamamoto R.

Cancer Sci. 2011 Jul;102(7):1298-305. doi: 10.1111/j.1349-7006.2011.01958.x. Epub 2011 May 26.

3.

MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma.

Qu K, Wang Z, Fan H, Li J, Liu J, Li P, Liang Z, An H, Jiang Y, Lin Q, Dong X, Liu P, Liu C.

Cell Death Dis. 2017 Feb 9;8(2):e2603. doi: 10.1038/cddis.2016.352. Erratum in: Cell Death Dis. 2018 Jun 7;9(6):681.

4.

Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma.

Guida T, Salvatore G, Faviana P, Giannini R, Garcia-Rostan G, Provitera L, Basolo F, Fusco A, Carlomagno F, Santoro M.

J Clin Endocrinol Metab. 2005 Aug;90(8):4703-9. Epub 2005 May 17.

PMID:
15899946
5.

Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7.

Shi YK, Yu YP, Tseng GC, Luo JH.

Cancer Gene Ther. 2010 Oct;17(10):694-9. doi: 10.1038/cgt.2010.25. Epub 2010 Jun 11.

6.

Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).

Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT, Shang L, Cao J, Song X, Wang BS, Cai Y, Zhan QM, Wang MR.

Lung Cancer. 2012 Jul;77(1):176-82. doi: 10.1016/j.lungcan.2012.03.001. Epub 2012 Mar 26.

PMID:
22456526
7.

Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer.

McCarthy S, Caporali A, Enkemann S, Scaltriti M, Eschrich S, Davalli P, Corti A, Lee A, Sung J, Yeatman TJ, Bettuzzi S.

Mol Oncol. 2007 Sep;1(2):196-204. doi: 10.1016/j.molonc.2007.05.007.

8.

Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary.

Ota T, Clayton AC, Minot DM, Shridhar V, Hartmann LC, Gilks CB, Chien JR.

Mod Pathol. 2011 Feb;24(2):277-87. doi: 10.1038/modpathol.2010.202. Epub 2010 Nov 12.

9.

Cell proliferation index determination by immunohistochemical detection of hCDC47 protein.

Rojiani MV, Siemann DW, Rojiani AM.

Appl Immunohistochem Mol Morphol. 2010 May;18(3):278-82. doi: 10.1097/PAI.0b013e3181c6c949.

PMID:
20048674
10.

miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.

Chuang TD, Luo X, Panda H, Chegini N.

Mol Endocrinol. 2012 Jun;26(6):1028-42. doi: 10.1210/me.2012-1075. Epub 2012 May 3.

11.

Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.

Kikuchi J, Kinoshita I, Shimizu Y, Kikuchi E, Takeda K, Aburatani H, Oizumi S, Konishi J, Kaga K, Matsuno Y, Birrer MJ, Nishimura M, Dosaka-Akita H.

Lung Cancer. 2011 May;72(2):229-37. doi: 10.1016/j.lungcan.2010.08.020. Epub 2010 Sep 29.

PMID:
20884074
12.

Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.

Aragaki M, Takahashi K, Akiyama H, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y.

Clin Cancer Res. 2011 Sep 15;17(18):5889-900. doi: 10.1158/1078-0432.CCR-11-0240. Epub 2011 Aug 3.

13.

Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis.

Zhong X, Guan X, Dong Q, Yang S, Liu W, Zhang L.

Tumour Biol. 2014 Jul;35(7):7155-62. doi: 10.1007/s13277-014-1935-8. Epub 2014 Apr 25.

PMID:
24763826
14.

Evaluation of minichromosome maintenance protein 7 as a prognostic marker in canine cutaneous mast cell tumours.

Berlato D, Stewart J, Newton R, Maglennon GA, Monti P, Flindall A, Murphy S.

Vet Comp Oncol. 2012 Jun;10(2):135-42. doi: 10.1111/j.1476-5829.2011.00287.x. Epub 2011 Sep 5.

PMID:
22235877
15.

Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections.

Tsai HY, Hsi BL, Hung IJ, Yang CP, Lin JN, Chen JC, Tsai SF, Huang SF.

Hum Pathol. 2004 Nov;35(11):1397-403.

PMID:
15668898
16.

Geminin expression in small lung adenocarcinomas: implication of prognostic significance.

Haruki T, Shomori K, Hamamoto Y, Taniguchi Y, Nakamura H, Ito H.

Lung Cancer. 2011 Mar;71(3):356-62. doi: 10.1016/j.lungcan.2010.06.013. Epub 2010 Jul 21.

PMID:
20650542
17.

Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion.

Lau KM, Chan QK, Pang JC, Li KK, Yeung WW, Chung NY, Lui PC, Tam YS, Li HM, Zhou L, Wang Y, Mao Y, Ng HK.

Oncogene. 2010 Oct 7;29(40):5475-89. doi: 10.1038/onc.2010.287. Epub 2010 Jul 26.

PMID:
20661220
18.

MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma.

Zhou YM, Zhang XF, Cao L, Li B, Sui CJ, Li YM, Yin ZF.

Liver Int. 2012 Nov;32(10):1505-9. doi: 10.1111/j.1478-3231.2012.02846.x. Epub 2012 Jul 12.

PMID:
22784096
19.

Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy.

Hou J, Lambers M, den Hamer B, den Bakker MA, Hoogsteden HC, Grosveld F, Hegmans J, Aerts J, Philipsen S.

J Thorac Oncol. 2012 Jan;7(1):105-14. doi: 10.1097/JTO.0b013e3182352a45.

20.

Supplemental Content

Support Center